Your browser doesn't support javascript.
loading
Comparison of Outcomes Between Banded and Non-banded Sleeve Gastrectomy: a Systematic Review and Meta-analysis.
Ponce de Leon-Ballesteros, Guillermo; Romero-Velez, Gustavo; Martinez-Portilla, Raigam Jafet; Pereira, Xavier; Roy-Garcia, Ivonne; Fobi, Mathias A L; Herrera, Miguel F.
Afiliação
  • Ponce de Leon-Ballesteros G; Department of Surgery, Hospital Civil de Morelia Miguel Silva, Morelia, Michoacan, Mexico.
  • Romero-Velez G; Department of Surgery, Montefiore Medical Center, Bronx, NY, USA.
  • Martinez-Portilla RJ; Clinical Research Division, National Institute of Perinatology, Mexico City, Mexico.
  • Pereira X; Fetal Surgery Clinic, ABC Medical Center, Mexico City, Mexico.
  • Roy-Garcia I; Department of Surgery, Montefiore Medical Center, Bronx, NY, USA.
  • Fobi MAL; Center for Training and Clinical Research, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Herrera MF; Mohak Bariatrics and Robotics Surgery Center, Indore, India.
Obes Surg ; 32(7): 1-12, 2022 07.
Article em En | MEDLINE | ID: mdl-35451804
ABSTRACT

BACKGROUND:

Sleeve gastrectomy (SG) is the most common bariatric procedure performed worldwide. It accounts for more than 50% of primary bariatric surgeries performed each year. Recent long-term data has shown an alarming trend of weight recidivism. Some authors have proposed the concurrent use of a non-adjustable gastric band to decrease long-term sleeve failure.

OBJECTIVE:

To compare the outcomes (weight loss) and safety (rate of complication and presence of upper GI symptoms) between SG and BSG.

METHODS:

A systematic search with no language or time restrictions was performed to identify relevant observational studies and randomized controlled trials (RCT) evaluating people with morbid obesity undergoing SG or SGB for weight loss. An inverse-of-the-variance meta-analysis was performed by random effects model. Heterogeneity was assessed using Cochrane X2 and I2 analysis.

RESULTS:

A total of 7 observational studies and 3 RCT were included in the final analysis. There were 911 participants pooled from observational studies and 194 from RCT. BSG showed a significant higher excess of weight loss (% EWL). The difference among groups was clinically relevant after the third year where the weighted mean difference (SMD) was 16.8 (CI 95% 12.45, 21.15, p < 0.0001), while at 5 years, a SMD of 25.59 (16.31, 34.87, p < 0.0001) was noticed. No differences related to overall complications were noticed. Upper GI symptoms were up to three times more frequent in the BSG group (OR 3.26. CI 95% 1.96, 5.42, p < 0.0001).

CONCLUSIONS:

According to the results, BSG is superior to SG in weight loss at 5 years but is associated with a higher incidence of upper GI symptoms. However, these conclusions are based mainly on data obtained from observational studies. Further RCT are needed to evaluate the effect and safety of BSG.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Derivação Gástrica / Cirurgia Bariátrica Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Derivação Gástrica / Cirurgia Bariátrica Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article